Login

scPharmaceuticals Inc. SEC Filings

Filed On Filing
11 Feb 2026 SCHEDULE 13G/A
19 Nov 2025 EFFECT
19 Nov 2025 EFFECT
19 Nov 2025 EFFECT
14 Nov 2025 SCHEDULE 13G/A
12 Nov 2025 SCHEDULE 13G
10 Nov 2025 SCHEDULE 13G/A
17 Oct 2025 15-12G
14 Oct 2025 SCHEDULE 13G
08 Oct 2025 SCHEDULE 13G/A
07 Oct 2025 Form 4: Schaeffer Leonard D, Director

Disposed of 111,900 shares (Tender Offer) · Disposed of 66,050 Stock Option (Right to Buy) (Disposition to Issuer)

07 Oct 2025 Form 4: Veitinger Klaus R Dr, Director

Disposed of 72,174 Stock Option (Right to Buy) (Disposition to Issuer)

07 Oct 2025 Form 4: Abraham William Tober, Director

Disposed of 66,050 Stock Option (Right to Buy) (Disposition to Issuer)

07 Oct 2025 Form 4: Baylor-Henry Minnie, Director

Disposed of 84,422 Stock Option (Right to Buy) (Disposition to Issuer)

07 Oct 2025 Form 4: Hudson Frederick M., Director

Disposed of 72,174 Stock Option (Right to Buy) (Disposition to Issuer)

07 Oct 2025 Form 4: Nokes Rachael, CFO and Treasurer

Disposed of 30,386 shares (Tender Offer) · Returned 125,675 shares to the issuer · Disposed of 207,646 Stock Option (Right to Buy) (Disposition to Issuer)

07 Oct 2025 Form 4: Tucker John H, Director

Disposed of 122,345 shares (Tender Offer) · Returned 318,502 shares to the issuer · Disposed of 1,130,174 Stock Option (Right to Buy) (Disposition to Issuer)

07 Oct 2025 Form 4: Agger Mette Kirstine, Director

Disposed of 49,750 Stock Option (Right to Buy) (Disposition to Issuer)

07 Oct 2025 Form 4: Bonstein Sara, Director

Disposed of 66,050 Stock Option (Right to Buy) (Disposition to Issuer)

07 Oct 2025 Form 4: Khattar Jack A., Director

Disposed of 5,000 shares (Tender Offer) · Disposed of 72,174 Stock Option (Right to Buy) (Disposition to Issuer)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support